Seattle Project Corporation

Quick facts

Phase 2 pipeline

• Fluoropyrimidine plus leucovorin · Oncology
  Inhibits thymidylate synthase
• GRT-C901 · Infectious Diseases
  GRT-C901 is a small molecule that targets the SARS-CoV-2 main protease.
• GRT-R902

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Seattle Project Corporation portfolio CI brief
• Seattle Project Corporation pipeline updates RSS